CClinicalTrials.gg
CompletedNCT02203448Updated Oct 19, 2018

Facet Wedge Post Market Study

An observational study in Chronic Low Back Pain, Degenerative Disc Disease and Facet Joint Disease, sponsored by Synthes GmbH. Completed at 3 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-10-19.

Sponsored by Synthes GmbH · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

A Multi-centre, Prospective, single-arm post market clinical follow up study (PMCF) of the FACET WEDGETM spinal system to assess outcomes in subjects with chronic low back pain due to Degenerative Disc Disease (DDD), facet joint disease and/or pseudo arthrosis post anterior instrumentation. The objective of this study is to assess outcomes following implantation of the FACET WEDGE spinal system when used to provide fixation of lumbar motion segments.

The primary objective of this study is to determine the rate of re-operations at the index level(s).

The secondary objectives of this study are to confirm the safety and performance of the device and to collect patient reported outcome data.

02

Conditions studied

  • Chronic Low Back Pain
  • Degenerative Disc Disease
  • Facet Joint Disease
  • Pseudo Arthrosis Post Anterior Instrumentation
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

The cases in the cohort are selected from patients treated in hospitals.

Inclusion criteria

  1. Subjects diagnosed with at least one of the following:

    • Degenerative Disc Disease (DDD);
    • Degenerative facet joint disease (isolated facet based symptomatic back pain);
    • Pseudoarthrosis post anterior instrumentation;
  2. Subjects who are a fusion candidate for single or multiple levels fusion between L1-S1;
  3. Subjects, who, in the opinion of the Investigator, are able to understand this clinical investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.

Exclusion criteria

Exclusion Criteria:

Preoperative exclusion criteria:

  1. Segmental instability of the index level in case of planned stand-alone FACET WEDGE usage;
  2. Unilateral application , except in combination with pediclescrew fixation on the contralateral side;
  3. Compromised facets due to decompression techniques;
  4. Spondylolisthesis;
  5. Fracture or other instabilities of the posterior elements;
  6. Tumor;
  7. Acute or chronic systemic or localized spinal infections;
  8. Nursing mothers or women who are pregnant or plan to become pregnant during the time of the study;
  9. Subjects aged below 18 years;
  10. Subjects who, in the opinion of the Investigator, have an existing condition that would compromise their participation and follow-up in this clinical investigation;

    Intraoperative exclusion criteria:

  11. Intraoperative decision to use implants other than the device under investigation.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (actual)
Patient registry
No

Groups and cohorts

  • FACET WEDGE spinal system

    The FACET WEDGE spinal system provides additional stability to a spinal segment to enhance fusion conditions.

    Device: Facet Wedge spinal system

Interventions

  • DeviceFacet Wedge spinal system
05

What researchers measure

Primary outcomes

  1. reoperation rate at the index level(s)

    Time frame: at two years

Secondary outcomes

  1. the radiographic range of motion (ROM) at the index levels

    Time frame: Pre-treatment, 6 months, 12 months, 24 months

  2. patient (back and leg) pain reported on a Numeric Rating Scale (NRS)

    Time frame: pre-treatment, prior to D/C, 6 weeks, 6 months, 12 months, 24 months.

  3. functional success based on results from the Oswestry Disability Index (ODI)

    Time frame: Pre-treatment, 6 weeks, 6 months, 12 months, 24 months

  4. Adverse events

    The nature and incidence of all procedural and post-treatment adverse events will be recorded and reported appropriately throughout the study to assess safety.

    Time frame: Throughout the study

06

Study locations

3 sites
  • BG Unfallklinik
    Frankfurt am Main, 60439, Germany
  • Schon Klinik Munchen
    Munchen, 81547, Germany
  • UVN
    Ruzomberok, Slovakia
07

Registry details

Key details

Study ID
NCT02203448
Lead sponsor
Synthes GmbH
Responsible party
Sponsor
First posted
Jul 30, 2014
Start date
May 1, 2014
Primary completion
Aug 31, 2018
Completion
Aug 31, 2018
Last update
Oct 19, 2018

Study contacts

Frank Kandziora, PhD
principal investigator · Berufsgenossenschaftliche Unfallklinik, Frankfurt am Main, Germany

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion